DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway

Table 2

Relationship between DAB2IP expression and clinic-pathological features in patients with gastric cancer.

Clinic parameters	Total	DAB2IP expression		value
		None or low	High
Age
<65	26	20	6	0.5471
≥65	30	25	5
Gender
Male	40	31	9	0.3948
Female	16	14	2
Tumor size
<5 cm	27	18	9	0.0128
≥5 cm	29	27	2
Tumor location
U&M	34	30	4	0.0651
L	22	15	7
Histological differentiation
Well or moderate	30	24	6	0.9424
Poor	26	21	5
Depth of invasion
T1-2	10	6	4	0.0738
T3-4	46	39	7
Lymph node metastasis
Yes	41	36	5	0.0204
No	15	9	6
TNM stage
I/II	17	10	7	0.0074
III/IV	39	35	4

; .